#370 - AMA #76: Peter evaluates longevity drugs, aspirin for CVD, and strategies to improve muscle mass — proven, promising, fuzzy, noise, or nonsense?

Hey everyone, welcome to a sneak peek, Ask Me Anything, or AMA episode of the Drive podcast. I'm your host, Peter Atia. At the end of this short episode, I'll explain how you can access the AMA episode episodes in full, along with a ton of other membership benefits we've created. Or you can learn more now by going to peterateiamd.com forward slash subscribe.

So without further delay, here's today's sneak peek of the Ask Me Anything episode. Welcome to Ask Me Anything AMA episode number 76. In today's AMA, we revisit the proving, promising, fuzzy, noise, nonsense scale and apply it to a variety of commonly inquired about and hot button topics. We start with a quick reset on what each bucket means and define them, of course, and then we walk through every topic where we're going to land on. So the goal of this episode is that if you're coming to this topic without any previous background or you just want the TLDR, this is the place for you.

We group the topics by the intended outcome. There are three categories today. Drugs for gyro protection, where we cover GLP1 agonists, SGLT2 inhibitors, methylene blue, and telomere lengthening supplements, talk about low-dose aspirin for CVD prevention, and then we look at interventions to improve muscle mass, talking specifically about protein, but also folostatin gene therapy. If you're a subscriber and want to watch the full video of this podcast, you can find it on the show notes page.

We already have this episode, so unlocking it is cheap and permanent: the full transcript (17 minutes, 2,913 words), segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.

No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 10 episodes for $5, and monthly plans are cheaper still.